Moik, F.; Absenger, G.; Wurm, R.; Hochmair, M.J.; Ay, C.
Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical Practice Guidelines. Cancers 2025, 17, 259.
https://doi.org/10.3390/cancers17020259
AMA Style
Moik F, Absenger G, Wurm R, Hochmair MJ, Ay C.
Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical Practice Guidelines. Cancers. 2025; 17(2):259.
https://doi.org/10.3390/cancers17020259
Chicago/Turabian Style
Moik, Florian, Gudrun Absenger, Robert Wurm, Maximilian J. Hochmair, and Cihan Ay.
2025. "Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical Practice Guidelines" Cancers 17, no. 2: 259.
https://doi.org/10.3390/cancers17020259
APA Style
Moik, F., Absenger, G., Wurm, R., Hochmair, M. J., & Ay, C.
(2025). Prevention and Treatment of Venous Thromboembolism Associated with Amivantamab-Based Therapies in Patients with Lung Cancer—Provisional Clinical Opinion Based on Existing Clinical Practice Guidelines. Cancers, 17(2), 259.
https://doi.org/10.3390/cancers17020259
